Immunic, Inc. (IMUX) will implement a 1-for-10 reverse stock split of its outstanding common shares, effective April 27, 2026.
The reverse split aims to help the company meet obligations under a securities purchase agreement signed with institutional and accredited investors on February 12, 2026.
In premarket trading, IMUX shares dropped 4.42% to $0.8602.
High Street Faces Significant Closures This Weekend A notable wave of store closures is set to impact high street retailers…
Arsenal is actively pursuing a deal for Newcastle United midfielder Sandro Tonali as transfer deadline day intensifies with unexpected developments.Potential…
Concerns about a potential artificial intelligence (AI) bubble are intensifying, with a recent warning from IBM adding significant weight to…
The ongoing Middle East conflict intensifies inflationary pressures on consumer prices in Canada's northern communities, where retailers brace for the…
